SlideShare a Scribd company logo
New Products
Our presentation contains information on each
item, including structures or diagrams.
To learn more, follow the link in the Product Name
to visit our website.
August 9 – August 15, 2016
11685 Bavachin
• Flavonoid that activates the estrogen receptors
ERα and ERβ (EC50s = 320 and 680 nM,
respectively)
• Stimulates osteoblast proliferation and
differentiation and prevents bone loss following
ovariectomy in rats
• Less potently inhibits acyl-coenzyme A:cholesterol
acyltransferase (IC50 = 86 µM)
Phytoestrogen
11844 α-Glycyrrhetinic Acid
• One of two epimers produced by removal of glucose from the
triterpenoid saponin glycyrrhizic acid (Item No. 11847), the
other being β-glycyrrhetinic acid (Item No. 11845)
• Inhibits intercellular communication through gap junctions
• Blocks gap junctions involving connexin-43 (also known as gap
junction α-1 protein) and connexin-26 (gap junction β-2 protein)
Gap junction blocker
19286 Esculetin
• A natural plant phenolic that shares features of
coumarins and catechols
• Inhibits 5-LO and 12-LO (ID50s = 4 and 2.5 µM,
respectively)
• Binds iron and also inhibits other iron-containing
enzymes, including the lysine-specific
demethylase KDM5B
• Promotes TRAIL-induced apoptosis in cancer cells
• Used as an antioxidant to reduce ROS and
modulate oxidant-sensitive enzymes
• Anti-fungal activities
Lipoxygenase inhibitor
19588 D-Fructose-6-phosphate (sodium salt)
• A sugar intermediate of the glycolytic pathway formed by the
isomerization of glucose-6-phosphate
• Further phosphorylated to fructose-1,6-bisphosphate, which is
one of the rate-limiting steps in glycolysis
• Because cancer cells adopt glycolysis as a major source of
metabolic energy production, this pathway has become a new
target for cancer chemotherapy
• Used to help identify, differentiate, and characterize the enzymes
in glycolysis
Glycolytic pathway intermediate
19716 NCT-502
• Inhibits PHGDH, inhibiting serine synthesis from 3-
phosphoglycerate in cells (IC50 = 3.7 µM)
• Reversibly blocks the production of glucose-derived
serine in cells
19718 NCT-503
• Inhibits PHGDH, inhibiting serine synthesis from 3-
phosphoglycerate in cells (IC50 = 2.5 µM)
• Reduces the production of glucose-derived serine in cells
• Suppresses the growth of PHGDH-dependent MDA-MB-
468 cancer cells both in vitro and in mice bearing
orthotopic xenograft tumors
3-phosphoglycerate dehydrogenase inhibitors
19847 Diosgenin
• A natural steroid sapogenin with antioxidant and anti-
inflammatory activities
• Protective against metabolic and cardiovascular diseases
and can have immunomodulatory and estrogenic effects
19849 Deoxyschizandrin
• A lignan with liver-protective, antitumor, and antioxidant
activities
• Adiponectin receptor 2 agonist (IC50 = 3.5 µM)
• Protective role in a rat model of myocardial ischemia-
reperfusion injury
• Down-regulates the increased production of nitric oxide,
TNF-α and IL-6 induced by LPSboth in BV-2 cells and
primary microglia cells
Natural antioxidants
19865 Procyanidin B2
• Flavanol with potent antioxidant activity
• A dimer of epicatechin (Item No. 11807) that scavenges hydroxyl
radical and superoxide anion more potently than epicatechin and
procyanidin B4
19867 Rhapontin
• A stilbenoid glycoside first isolated from rhubarb rhizomes
• Converted by glucosidases to rhapontigenin (Item No. 13293), a
resveratrol analog with antioxidant and anti-cancer activity
19868 Rutin (hydrate)
• A flavonol glycoside with iron chelating and antioxidant properties
• Anti-inflammatory, anti-cancer, and anti-fibrosis effects and displays
hepato- and neuroprotective actions
Natural antioxidants
19861 Paeoniflorin
• Monoterpene glycoside that modulates NMDA and TRPV1
receptors
• Inhibits testosterone synthesis and stimulates aromatase
activity
• Reduces inflammatory signaling by inhibiting p38 MAP
kinase
• Blocks pancreatic cancer cell apoptosis by suppressing
MMP-9 and ERK signaling
• Analgesic and anti-inflammatory actions
19862 Paeonol
• Phenolic compound with anti-oxidative actions
• Analgesic, anti-inflammatory, and hepatoprotective effects
Analgesics
19870 Chrysophanol
• An anthraquinone with antibacterial, antiviral, anti-inflammatory, and anticancer activities
• Inhibits hepatitis B viral DNA production and HBsAg secretion in HepG2 2.2.15 cells.
• Reduces the level of nitric oxide and PGE2 production by diminishing the expression of
inducible nitric oxide synthase and COX-2 in BV2 microglia
• Induces necrosis through the production of ROS in J5 human liver cancer cells
19873 Isobavachalcone
• Chalcone with antibacterial, antifungal, anticancer, anti-reverse transcriptase, antitubercular,
and antioxidant activities
• Inhibits the growth of MGC803 gastric cancer cells by regulating the protein expression of
caspase-3, Bcl-2, and Bax and by inhibiting Akt and ERK signaling pathways
• Inhibits oligomerization and fibrillization of Aβ42 in an SH-SY5Y cell model of Aβ42 aggregation
Antibacterial/ Antiviral
19872 Ginkgolide C
• Flavone with a selective platelet activating factor
receptor antagonist (IC50 = 37.6 μM)
• Increases lipolysis and inhibits adipogenesis in
adipocytes via the activated AMPK pathway
PAF receptor antagonist
20184 Oligomycin D
• Inhibits the mitochondrial F1FO-ATPase
• Used to uncouple oxidative phosphorylation from
electron transport
• Inhibits K-Ras plasma membrane localization in MDCK
cells (IC50 = 3.49 nM) and is cytotoxic to SW620 colon
cancer cells (IC50 = 36 µM)
20185 Oligomycin E
• Exhibits relatively weak antifungal activity compared to
other oligomycins, yet is active against Gram-positive
bacteria
• Demonstrates strong antitumor activity against HeLa
cells (IC50 = 14 ng/ml)
Antibiotics
20188 Teicoplanin A2-3
• Major component of the teicoplanin complex that is
broadly effective against Gram-positive bacteria
20189 Teicoplanin A2-4
• Component of the teicoplanin complex that is broadly
effective against Gram-positive bacteria
20192 Teicoplanin A2-5
• The most non-polar metabolite in the family of
teicoplanins
20193 Teicoplanin A3-1
• Degradation product of teicoplanins A2-1 to 5
Antibiotics
9002780 1-(4-Fluorophenyl)-2-methyl-2-propylamine
• A fluorinated building block used for the synthesis of various
pharmaceutical amides
Building block
20061 MDMB-FUBINACA metabolite M1
• An expected metabolite of MDMB-FUBINACA and ADB-FUBINACA
17761 AB-FUBINACA metabolite 3
• An expected metabolite of AB-FUBINACA
19730 5-fluoro BEPIRAPIM (hydrochloride)
• A synthetic cannabinoid whose physiological and toxicological
properties are not known
Forensic Science
19567 ortho-Fluorobutyryl fentanyl (hydrochloride)
• An opioid whose physiological and toxicological properties are not known
19735 para-Fluorofentanyl (hydrochloride) (CRM)
• Activates the human μ opioid receptor with greater potency than fentanyl
(EC50s = 4.2 and 28.8 nM for para-fluorofentanyl and fentanyl, respectively)
19736 β-Hydroxythiofentanyl (hydrochloride) (CRM)
• An opioid regulated as a Schedule I controlled substance in the United States
19883 Benzyl fentanyl (hydrochloride)
• An opioid that is reported to have low opioid activity in a mouse analgesia hot
plate assay
Forensic Science
19737 MT-45 (hydrochloride) (CRM)
• A piperazine that displays potent analgesic activity
comparable to morphine despite being structurally
unrelated to most other opioids
19794 Tiletamine (hydrochloride)
• A non-competitive NMDA receptor antagonist used in
veterinary medicine for its anesthetic and sedative
properties, which are comparable to ketamine
19745 2,6-DMA (hydrochloride)
• An amphetamine that acts as a serotonin 5-HT2 receptor
agonist (apparent pA2 = 5.09)
Forensic Science
19275 4’-methoxy-α-Ethylaminovalerophenone (hydrochloride)
• A cathinone whose physiological and toxicological properties are not known
20132 Benzocaine
• A topical anesthetic commonly found as an adulterant in cocaine
20200 5α-dihydro-11-keto Testosterone
• A metabolite of 11β-hydroxyandrostenedione and 11β-hydroxytestosterone that has
been shown to act as a full androgen receptor agonist with equal potency as that of
dihydrotestosterone
Forensic Science
19222 AH 7921-d3 (CRM)
• An internal standard for the quantification of AH7921 by GC- or LC-MS
19507 MT-45-d11 (hydrochloride) (CRM)
• An internal standard for the quantification of MT-45 by GC- or LC-MS
19928 Fentanyl-d5 (hydrochloride) (CRM)
• An internal standard for the quantification of fentanyl by GC- or LC-MS
19947 β-Hydroxythiofentanyl-d5 (hydrochloride) (CRM)
• An internal standard for the quantification of β-hydroxythiofentanyl
(hydrochloride) by GC- or LC-MS
Forensic Science

More Related Content

What's hot

Protease Inhibition
Protease InhibitionProtease Inhibition
Protease Inhibition
PXB
 
resveratrol and glutamat
resveratrol and glutamatresveratrol and glutamat
resveratrol and glutamat
tarbiat modares university
 
Immunosuppressive drugs
Immunosuppressive drugsImmunosuppressive drugs
Immunosuppressive drugs
Ayatollah Abdel-sattar
 
Novozymes Veltis® – Engineerd albumins for optimized drug dosing
Novozymes Veltis® – Engineerd albumins for optimized drug dosingNovozymes Veltis® – Engineerd albumins for optimized drug dosing
Novozymes Veltis® – Engineerd albumins for optimized drug dosing
Niklas Andersson
 
Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)
Dr.Kavitha Vivek
 
Fish protein hydrolysate (fph)-kashmeera
Fish protein hydrolysate (fph)-kashmeeraFish protein hydrolysate (fph)-kashmeera
Fish protein hydrolysate (fph)-kashmeera
Kashmeera N.A.
 
Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)
Clearsky Pharmacy
 
Hepatoprotective agents
Hepatoprotective agentsHepatoprotective agents
Hepatoprotective agents
Subodh Chataut
 
Introduction of immunity and immunosuppressed drugs
Introduction of immunity  and immunosuppressed drugsIntroduction of immunity  and immunosuppressed drugs
Introduction of immunity and immunosuppressed drugs
Abdikadir Daahir
 
Alkylating agents
Alkylating agentsAlkylating agents
Alkylating agents
Money Kalash
 
Recombinant Proteins
Recombinant ProteinsRecombinant Proteins
Recombinant Proteins
Jesús C. Morales
 
Drugs acting on ppar
Drugs acting on pparDrugs acting on ppar
Drugs acting on ppar
podila shree
 
Fish protein hydrolysate
Fish protein hydrolysateFish protein hydrolysate
Fish protein hydrolysate
Krishna Paudel
 
Recombinant protein
Recombinant protein Recombinant protein
Recombinant protein
Deepa Muricken
 
Quercetin- A Mini Review-Crimson Publishers
Quercetin- A Mini Review-Crimson PublishersQuercetin- A Mini Review-Crimson Publishers
Quercetin- A Mini Review-Crimson Publishers
CrimsonpublishersMCDA
 
Applications of enzymes_in_pharmaceutica
Applications of enzymes_in_pharmaceuticaApplications of enzymes_in_pharmaceutica
Applications of enzymes_in_pharmaceutica
vishnugm
 
My healthcare biotech
My healthcare biotechMy healthcare biotech
My healthcare biotech
OmBagade1
 

What's hot (20)

Protease Inhibition
Protease InhibitionProtease Inhibition
Protease Inhibition
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
 
project work
project workproject work
project work
 
resveratrol and glutamat
resveratrol and glutamatresveratrol and glutamat
resveratrol and glutamat
 
Immunosuppressive drugs
Immunosuppressive drugsImmunosuppressive drugs
Immunosuppressive drugs
 
Novozymes Veltis® – Engineerd albumins for optimized drug dosing
Novozymes Veltis® – Engineerd albumins for optimized drug dosingNovozymes Veltis® – Engineerd albumins for optimized drug dosing
Novozymes Veltis® – Engineerd albumins for optimized drug dosing
 
Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)
 
Fish protein hydrolysate (fph)-kashmeera
Fish protein hydrolysate (fph)-kashmeeraFish protein hydrolysate (fph)-kashmeera
Fish protein hydrolysate (fph)-kashmeera
 
Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)Imalek (Imatinib Mesylate Tablets)
Imalek (Imatinib Mesylate Tablets)
 
Hepatoprotective agents
Hepatoprotective agentsHepatoprotective agents
Hepatoprotective agents
 
Introduction of immunity and immunosuppressed drugs
Introduction of immunity  and immunosuppressed drugsIntroduction of immunity  and immunosuppressed drugs
Introduction of immunity and immunosuppressed drugs
 
Alkylating agents
Alkylating agentsAlkylating agents
Alkylating agents
 
Recombinant Proteins
Recombinant ProteinsRecombinant Proteins
Recombinant Proteins
 
Awakush
AwakushAwakush
Awakush
 
Drugs acting on ppar
Drugs acting on pparDrugs acting on ppar
Drugs acting on ppar
 
Fish protein hydrolysate
Fish protein hydrolysateFish protein hydrolysate
Fish protein hydrolysate
 
Recombinant protein
Recombinant protein Recombinant protein
Recombinant protein
 
Quercetin- A Mini Review-Crimson Publishers
Quercetin- A Mini Review-Crimson PublishersQuercetin- A Mini Review-Crimson Publishers
Quercetin- A Mini Review-Crimson Publishers
 
Applications of enzymes_in_pharmaceutica
Applications of enzymes_in_pharmaceuticaApplications of enzymes_in_pharmaceutica
Applications of enzymes_in_pharmaceutica
 
My healthcare biotech
My healthcare biotechMy healthcare biotech
My healthcare biotech
 

Similar to Cayman Chemical - Weekly New Products

Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
BiologInc
 
Cancer cell signaling and its mechanisms.pptx
Cancer cell signaling and its mechanisms.pptxCancer cell signaling and its mechanisms.pptx
Cancer cell signaling and its mechanisms.pptx
pharmanotesready
 
MT program meeting seminar on 01-15-2014 v2
MT program meeting seminar on 01-15-2014 v2MT program meeting seminar on 01-15-2014 v2
MT program meeting seminar on 01-15-2014 v2Hosam A. Elbaz, PhD, RPh
 
Neuroprotective Herbal Plants - A Review
Neuroprotective Herbal Plants - A ReviewNeuroprotective Herbal Plants - A Review
Neuroprotective Herbal Plants - A Review
AI Publications
 
Anup p.( k channel opener)
Anup p.( k channel opener)Anup p.( k channel opener)
Anup p.( k channel opener)
DR ANUP PETARE
 
Targeted therapy psoriasis
Targeted therapy psoriasisTargeted therapy psoriasis
Targeted therapy psoriasisDr. Aseem Sharma
 
UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]
UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]
UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]Hosam A. Elbaz, PhD, RPh
 
750903.pptx
750903.pptx750903.pptx
750903.pptx
Ashiqur Rahman
 
study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...
Subham Kumar Vishwakarma
 
Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)Mary Hair
 
Soursop
SoursopSoursop
Soursop
Astha Sanyal
 
yslides2453189g9oodfineandverygoood.pptx
yslides2453189g9oodfineandverygoood.pptxyslides2453189g9oodfineandverygoood.pptx
yslides2453189g9oodfineandverygoood.pptx
aaaa bbb
 
Eicosanoids.pptx
Eicosanoids.pptxEicosanoids.pptx
Eicosanoids.pptx
OcquliVictor
 
Class immunosuppressants 2
Class immunosuppressants 2Class immunosuppressants 2
Class immunosuppressants 2Raghu Prasada
 
عرض تقديمي أميرة 2018.ppt
عرض تقديمي أميرة 2018.pptعرض تقديمي أميرة 2018.ppt
عرض تقديمي أميرة 2018.ppt
MajdolenAhrki
 
Seminar 4 prostaglandins and leucotrienes
Seminar 4 prostaglandins and leucotrienesSeminar 4 prostaglandins and leucotrienes
Seminar 4 prostaglandins and leucotrienes
Rushikesh Kulkarni
 
Cytoprotective agents
Cytoprotective agentsCytoprotective agents
Cytoprotective agents
DrkiranPanchal
 
Tissue specificity of phenyl proponoids
Tissue specificity of phenyl proponoids Tissue specificity of phenyl proponoids
Tissue specificity of phenyl proponoids
prakashsp13
 
Antioxidants treatment for diabetes mellitus.pptx
Antioxidants treatment for diabetes mellitus.pptxAntioxidants treatment for diabetes mellitus.pptx
Antioxidants treatment for diabetes mellitus.pptx
Praveen kumar S
 

Similar to Cayman Chemical - Weekly New Products (20)

Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...
 
Cancer cell signaling and its mechanisms.pptx
Cancer cell signaling and its mechanisms.pptxCancer cell signaling and its mechanisms.pptx
Cancer cell signaling and its mechanisms.pptx
 
CMMG seminar on 11072013 11-06-2013
CMMG seminar on 11072013 11-06-2013CMMG seminar on 11072013 11-06-2013
CMMG seminar on 11072013 11-06-2013
 
MT program meeting seminar on 01-15-2014 v2
MT program meeting seminar on 01-15-2014 v2MT program meeting seminar on 01-15-2014 v2
MT program meeting seminar on 01-15-2014 v2
 
Neuroprotective Herbal Plants - A Review
Neuroprotective Herbal Plants - A ReviewNeuroprotective Herbal Plants - A Review
Neuroprotective Herbal Plants - A Review
 
Anup p.( k channel opener)
Anup p.( k channel opener)Anup p.( k channel opener)
Anup p.( k channel opener)
 
Targeted therapy psoriasis
Targeted therapy psoriasisTargeted therapy psoriasis
Targeted therapy psoriasis
 
UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]
UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]
UMich meeting seminar on 03-12-2014 v1.pptx [Autosaved]
 
750903.pptx
750903.pptx750903.pptx
750903.pptx
 
study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...study of natural products as leads for new pharmaceuticals for the various cl...
study of natural products as leads for new pharmaceuticals for the various cl...
 
Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)Cholinergic drugs 1 (1)
Cholinergic drugs 1 (1)
 
Soursop
SoursopSoursop
Soursop
 
yslides2453189g9oodfineandverygoood.pptx
yslides2453189g9oodfineandverygoood.pptxyslides2453189g9oodfineandverygoood.pptx
yslides2453189g9oodfineandverygoood.pptx
 
Eicosanoids.pptx
Eicosanoids.pptxEicosanoids.pptx
Eicosanoids.pptx
 
Class immunosuppressants 2
Class immunosuppressants 2Class immunosuppressants 2
Class immunosuppressants 2
 
عرض تقديمي أميرة 2018.ppt
عرض تقديمي أميرة 2018.pptعرض تقديمي أميرة 2018.ppt
عرض تقديمي أميرة 2018.ppt
 
Seminar 4 prostaglandins and leucotrienes
Seminar 4 prostaglandins and leucotrienesSeminar 4 prostaglandins and leucotrienes
Seminar 4 prostaglandins and leucotrienes
 
Cytoprotective agents
Cytoprotective agentsCytoprotective agents
Cytoprotective agents
 
Tissue specificity of phenyl proponoids
Tissue specificity of phenyl proponoids Tissue specificity of phenyl proponoids
Tissue specificity of phenyl proponoids
 
Antioxidants treatment for diabetes mellitus.pptx
Antioxidants treatment for diabetes mellitus.pptxAntioxidants treatment for diabetes mellitus.pptx
Antioxidants treatment for diabetes mellitus.pptx
 

Recently uploaded

Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Product School
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
DianaGray10
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
Product School
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
DianaGray10
 
Elevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object CalisthenicsElevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object Calisthenics
Dorra BARTAGUIZ
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
UiPathCommunity
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
KatiaHIMEUR1
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
ControlCase
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
91mobiles
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
ThousandEyes
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
g2nightmarescribd
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
Sri Ambati
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
RTTS
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
Product School
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
BookNet Canada
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
Frank van Harmelen
 

Recently uploaded (20)

Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
Unsubscribed: Combat Subscription Fatigue With a Membership Mentality by Head...
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
 
How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...How world-class product teams are winning in the AI era by CEO and Founder, P...
How world-class product teams are winning in the AI era by CEO and Founder, P...
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4UiPath Test Automation using UiPath Test Suite series, part 4
UiPath Test Automation using UiPath Test Suite series, part 4
 
Elevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object CalisthenicsElevating Tactical DDD Patterns Through Object Calisthenics
Elevating Tactical DDD Patterns Through Object Calisthenics
 
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
Dev Dives: Train smarter, not harder – active learning and UiPath LLMs for do...
 
Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !Securing your Kubernetes cluster_ a step-by-step guide to success !
Securing your Kubernetes cluster_ a step-by-step guide to success !
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
PCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase TeamPCI PIN Basics Webinar from the Controlcase Team
PCI PIN Basics Webinar from the Controlcase Team
 
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdfSmart TV Buyer Insights Survey 2024 by 91mobiles.pdf
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf
 
Assuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyesAssuring Contact Center Experiences for Your Customers With ThousandEyes
Assuring Contact Center Experiences for Your Customers With ThousandEyes
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
Generating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using SmithyGenerating a custom Ruby SDK for your web service or Rails API using Smithy
Generating a custom Ruby SDK for your web service or Rails API using Smithy
 
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
GenAISummit 2024 May 28 Sri Ambati Keynote: AGI Belongs to The Community in O...
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
 
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
From Siloed Products to Connected Ecosystem: Building a Sustainable and Scala...
 
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...Transcript: Selling digital books in 2024: Insights from industry leaders - T...
Transcript: Selling digital books in 2024: Insights from industry leaders - T...
 
Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*Neuro-symbolic is not enough, we need neuro-*semantic*
Neuro-symbolic is not enough, we need neuro-*semantic*
 

Cayman Chemical - Weekly New Products

  • 2. Our presentation contains information on each item, including structures or diagrams. To learn more, follow the link in the Product Name to visit our website.
  • 3. August 9 – August 15, 2016
  • 4. 11685 Bavachin • Flavonoid that activates the estrogen receptors ERα and ERβ (EC50s = 320 and 680 nM, respectively) • Stimulates osteoblast proliferation and differentiation and prevents bone loss following ovariectomy in rats • Less potently inhibits acyl-coenzyme A:cholesterol acyltransferase (IC50 = 86 µM) Phytoestrogen
  • 5. 11844 α-Glycyrrhetinic Acid • One of two epimers produced by removal of glucose from the triterpenoid saponin glycyrrhizic acid (Item No. 11847), the other being β-glycyrrhetinic acid (Item No. 11845) • Inhibits intercellular communication through gap junctions • Blocks gap junctions involving connexin-43 (also known as gap junction α-1 protein) and connexin-26 (gap junction β-2 protein) Gap junction blocker
  • 6. 19286 Esculetin • A natural plant phenolic that shares features of coumarins and catechols • Inhibits 5-LO and 12-LO (ID50s = 4 and 2.5 µM, respectively) • Binds iron and also inhibits other iron-containing enzymes, including the lysine-specific demethylase KDM5B • Promotes TRAIL-induced apoptosis in cancer cells • Used as an antioxidant to reduce ROS and modulate oxidant-sensitive enzymes • Anti-fungal activities Lipoxygenase inhibitor
  • 7. 19588 D-Fructose-6-phosphate (sodium salt) • A sugar intermediate of the glycolytic pathway formed by the isomerization of glucose-6-phosphate • Further phosphorylated to fructose-1,6-bisphosphate, which is one of the rate-limiting steps in glycolysis • Because cancer cells adopt glycolysis as a major source of metabolic energy production, this pathway has become a new target for cancer chemotherapy • Used to help identify, differentiate, and characterize the enzymes in glycolysis Glycolytic pathway intermediate
  • 8. 19716 NCT-502 • Inhibits PHGDH, inhibiting serine synthesis from 3- phosphoglycerate in cells (IC50 = 3.7 µM) • Reversibly blocks the production of glucose-derived serine in cells 19718 NCT-503 • Inhibits PHGDH, inhibiting serine synthesis from 3- phosphoglycerate in cells (IC50 = 2.5 µM) • Reduces the production of glucose-derived serine in cells • Suppresses the growth of PHGDH-dependent MDA-MB- 468 cancer cells both in vitro and in mice bearing orthotopic xenograft tumors 3-phosphoglycerate dehydrogenase inhibitors
  • 9. 19847 Diosgenin • A natural steroid sapogenin with antioxidant and anti- inflammatory activities • Protective against metabolic and cardiovascular diseases and can have immunomodulatory and estrogenic effects 19849 Deoxyschizandrin • A lignan with liver-protective, antitumor, and antioxidant activities • Adiponectin receptor 2 agonist (IC50 = 3.5 µM) • Protective role in a rat model of myocardial ischemia- reperfusion injury • Down-regulates the increased production of nitric oxide, TNF-α and IL-6 induced by LPSboth in BV-2 cells and primary microglia cells Natural antioxidants
  • 10. 19865 Procyanidin B2 • Flavanol with potent antioxidant activity • A dimer of epicatechin (Item No. 11807) that scavenges hydroxyl radical and superoxide anion more potently than epicatechin and procyanidin B4 19867 Rhapontin • A stilbenoid glycoside first isolated from rhubarb rhizomes • Converted by glucosidases to rhapontigenin (Item No. 13293), a resveratrol analog with antioxidant and anti-cancer activity 19868 Rutin (hydrate) • A flavonol glycoside with iron chelating and antioxidant properties • Anti-inflammatory, anti-cancer, and anti-fibrosis effects and displays hepato- and neuroprotective actions Natural antioxidants
  • 11. 19861 Paeoniflorin • Monoterpene glycoside that modulates NMDA and TRPV1 receptors • Inhibits testosterone synthesis and stimulates aromatase activity • Reduces inflammatory signaling by inhibiting p38 MAP kinase • Blocks pancreatic cancer cell apoptosis by suppressing MMP-9 and ERK signaling • Analgesic and anti-inflammatory actions 19862 Paeonol • Phenolic compound with anti-oxidative actions • Analgesic, anti-inflammatory, and hepatoprotective effects Analgesics
  • 12. 19870 Chrysophanol • An anthraquinone with antibacterial, antiviral, anti-inflammatory, and anticancer activities • Inhibits hepatitis B viral DNA production and HBsAg secretion in HepG2 2.2.15 cells. • Reduces the level of nitric oxide and PGE2 production by diminishing the expression of inducible nitric oxide synthase and COX-2 in BV2 microglia • Induces necrosis through the production of ROS in J5 human liver cancer cells 19873 Isobavachalcone • Chalcone with antibacterial, antifungal, anticancer, anti-reverse transcriptase, antitubercular, and antioxidant activities • Inhibits the growth of MGC803 gastric cancer cells by regulating the protein expression of caspase-3, Bcl-2, and Bax and by inhibiting Akt and ERK signaling pathways • Inhibits oligomerization and fibrillization of Aβ42 in an SH-SY5Y cell model of Aβ42 aggregation Antibacterial/ Antiviral
  • 13. 19872 Ginkgolide C • Flavone with a selective platelet activating factor receptor antagonist (IC50 = 37.6 μM) • Increases lipolysis and inhibits adipogenesis in adipocytes via the activated AMPK pathway PAF receptor antagonist
  • 14. 20184 Oligomycin D • Inhibits the mitochondrial F1FO-ATPase • Used to uncouple oxidative phosphorylation from electron transport • Inhibits K-Ras plasma membrane localization in MDCK cells (IC50 = 3.49 nM) and is cytotoxic to SW620 colon cancer cells (IC50 = 36 µM) 20185 Oligomycin E • Exhibits relatively weak antifungal activity compared to other oligomycins, yet is active against Gram-positive bacteria • Demonstrates strong antitumor activity against HeLa cells (IC50 = 14 ng/ml) Antibiotics
  • 15. 20188 Teicoplanin A2-3 • Major component of the teicoplanin complex that is broadly effective against Gram-positive bacteria 20189 Teicoplanin A2-4 • Component of the teicoplanin complex that is broadly effective against Gram-positive bacteria 20192 Teicoplanin A2-5 • The most non-polar metabolite in the family of teicoplanins 20193 Teicoplanin A3-1 • Degradation product of teicoplanins A2-1 to 5 Antibiotics
  • 16. 9002780 1-(4-Fluorophenyl)-2-methyl-2-propylamine • A fluorinated building block used for the synthesis of various pharmaceutical amides Building block
  • 17. 20061 MDMB-FUBINACA metabolite M1 • An expected metabolite of MDMB-FUBINACA and ADB-FUBINACA 17761 AB-FUBINACA metabolite 3 • An expected metabolite of AB-FUBINACA 19730 5-fluoro BEPIRAPIM (hydrochloride) • A synthetic cannabinoid whose physiological and toxicological properties are not known Forensic Science
  • 18. 19567 ortho-Fluorobutyryl fentanyl (hydrochloride) • An opioid whose physiological and toxicological properties are not known 19735 para-Fluorofentanyl (hydrochloride) (CRM) • Activates the human μ opioid receptor with greater potency than fentanyl (EC50s = 4.2 and 28.8 nM for para-fluorofentanyl and fentanyl, respectively) 19736 β-Hydroxythiofentanyl (hydrochloride) (CRM) • An opioid regulated as a Schedule I controlled substance in the United States 19883 Benzyl fentanyl (hydrochloride) • An opioid that is reported to have low opioid activity in a mouse analgesia hot plate assay Forensic Science
  • 19. 19737 MT-45 (hydrochloride) (CRM) • A piperazine that displays potent analgesic activity comparable to morphine despite being structurally unrelated to most other opioids 19794 Tiletamine (hydrochloride) • A non-competitive NMDA receptor antagonist used in veterinary medicine for its anesthetic and sedative properties, which are comparable to ketamine 19745 2,6-DMA (hydrochloride) • An amphetamine that acts as a serotonin 5-HT2 receptor agonist (apparent pA2 = 5.09) Forensic Science
  • 20. 19275 4’-methoxy-α-Ethylaminovalerophenone (hydrochloride) • A cathinone whose physiological and toxicological properties are not known 20132 Benzocaine • A topical anesthetic commonly found as an adulterant in cocaine 20200 5α-dihydro-11-keto Testosterone • A metabolite of 11β-hydroxyandrostenedione and 11β-hydroxytestosterone that has been shown to act as a full androgen receptor agonist with equal potency as that of dihydrotestosterone Forensic Science
  • 21. 19222 AH 7921-d3 (CRM) • An internal standard for the quantification of AH7921 by GC- or LC-MS 19507 MT-45-d11 (hydrochloride) (CRM) • An internal standard for the quantification of MT-45 by GC- or LC-MS 19928 Fentanyl-d5 (hydrochloride) (CRM) • An internal standard for the quantification of fentanyl by GC- or LC-MS 19947 β-Hydroxythiofentanyl-d5 (hydrochloride) (CRM) • An internal standard for the quantification of β-hydroxythiofentanyl (hydrochloride) by GC- or LC-MS Forensic Science